Covid-19 Antigen Rapid Test Kit - 25/kit

The Clarity Covid-19 Antigen Rapid Test Kit is a simple and efficient rapid chromatographic immunoassay test used by healthcare professionals for the direct and qualitative detection of Coronavirus (Sars-CoV-2) antigens collected through nasopharyngeal swabbing from patients. CLIA-waived and approved for point-of-care testing, this rapid test can be used for individuals who are suspected of Covid-19, and are within six days of symptom onset.

Reliable & Easy to Use: This Covid-19 Antigen Rapid Test Kit comes with specimen sampling swabs, extraction reagents, and test cassettes. Gathered nasal swab samples are mixed with the reagent immediately, making sure that enough specimen is well incorporated into the buffer solution, which is then dispensed (3 drops) into the sample well of the test cassette. Fast and precise results will be available within 10 minutes, which essentially boosts medical facilities’ capacity to conduct more in-patient rapid COVID-19 tests, resulting in faster identification of infectious individuals and contact tracing.

Quick and Accurate: Please take note that accurate results will be shown 10 minutes after applying the sample and should not exceed 20 minutes to avoid reading false positive or negative results. A solo colored horizontal mark on the "C" (control) area depicts that you have a negative result while a positive result shows two colored marks for the "C" and "T" (test) zones. Invalid results show no lines on the "C" zone. This rapid test can identify infection in patients with 87.5% sensitivity and greater than 98.9% specificity.

FDA Disclaimer: This swab test kit is only authorized under an Emergency Use Authorization for point of care use. It is authorized for the rapid detection of proteins from SARS-CoV-2 and not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.